Improving Outcomes with Surgical Resection and Other Ablative Therapies in HCC. - Wikidata - awgldk - TriplyDB

Improving Outcomes with Surgical Resection and Other Ablative Therapies in HCC.

Improving Outcomes with Surgical Resection and Other Ablative Therapies in HCC.

http://www.wikidata.org/entity/Q35207762

about

Imaging of hepatocellular carcinoma: diagnosis, staging and treatment monitoring TAT-LHRH conjugated low molecular weight chitosan as a gene carrier specific for hepatocellular carcinoma cells CCAT1 promotes hepatocellular carcinoma cell proliferation and invasion.Microarray profiling shows distinct differences between primary tumors and commonly used preclinical models in hepatocellular carcinoma.Radioablation of liver malignancies with interstitial high-dose-rate brachytherapy : Complications and risk factors.Biodistribution of TAT-LHRH conjugated chitosan/DNA nanoparticles in the mice bearing hepatoma xenografts.Novel SAHA analogues inhibit HDACs, induce apoptosis and modulate the expression of microRNAs in hepatocellular carcinoma.

P2860

Q30436747-F9D8C71C-24F0-42FF-BE2B-11D9383D9C00 Q33769475-45D171EB-38FE-42E7-B25D-F5C6256B3891 Q34485865-376251A2-0964-4091-B2F7-BAE07FEEA532 Q35828338-67D7E4EF-71ED-4F0F-98B6-6068FCF83BE3 Q39962478-227B7655-B1EB-4FAB-BFDB-7850A02E4EFF Q45885714-6F054BA9-C56E-4A6C-AF2D-92E30AC465B5 Q51584555-3D70ED23-C212-4CD0-A5BB-7FC6A09E52CD

P2860

Improving Outcomes with Surgical Resection and Other Ablative Therapies in HCC.

http://www.wikidata.org/entity/Q35207762

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Improving Outcomes with Surgical Resection and Other Ablative Therapies in HCC.

@ast

Improving Outcomes with Surgical Resection and Other Ablative Therapies in HCC.

@en

type

label

Improving Outcomes with Surgical Resection and Other Ablative Therapies in HCC.

@ast

Improving Outcomes with Surgical Resection and Other Ablative Therapies in HCC.

@en

prefLabel

Improving Outcomes with Surgical Resection and Other Ablative Therapies in HCC.

@ast

Improving Outcomes with Surgical Resection and Other Ablative Therapies in HCC.

@en

P1433

Q35207762-30C09B0E-FFD8-4E64-A287-3981D98321AF

P1476

Q35207762-DFC0907B-7A92-4306-8878-3111EA98BCF0

P2093

Q35207762-4D281987-5D49-4D3C-B1DC-8FE19F0DF9EC

Q35207762-781FCDC0-5A70-458A-81D5-E5D8D11BB386

P2860

Q35207762-01FBFEEE-BAEE-4C65-A8E8-930802EBE519

Q35207762-0662DF6B-0F49-4EF3-AD5C-8E1C6C2DDDD2

Q35207762-0D52EE05-10C4-47DB-8B39-B497E566D701

Q35207762-0ED8DEDC-0412-4FCE-A7D2-F86F8360F6F5

Q35207762-19DA2BCE-5B34-4889-B689-57F77E09024A

Q35207762-1FF1573C-8161-496C-8DB3-B61C499BD9E6

Q35207762-248FAAC0-9D98-45A5-A6E7-275D245C1667

Q35207762-28F7036E-178F-4CB7-A475-2B0FF93AB7DC

Q35207762-2F378D95-66E9-426A-88DE-D07FA822BEEA

Q35207762-34DBE91C-3232-4001-BEC5-DC5EE767C1A4

P304

Q35207762-4FA39DB1-DDD0-480F-BF8B-BCA8EF5C1D6F

P31

Q35207762-A19DBC57-9C32-4414-9A7B-EBD9D5AE4748

P356

Q35207762-E13AA21D-90F3-4F04-8874-88151BB635ED

P478

Q35207762-1638AE5B-615C-45FD-944C-0EF3F06C9C8D

P50

Q35207762-A0D6960C-734B-43FD-B5F3-E7EE182B6DE5

P577

Q35207762-3BB6EE02-B8DD-4329-84C4-9D25C3249F80

P5875

Q35207762-7DCB216D-2E3C-4478-A0E6-6EA8DF5C09D0

P698

Q35207762-15B7B59B-0E85-45AE-96ED-33BFC24C68B7

P932

Q35207762-7FA99384-F2D0-41B6-9A39-E2F35BE26B82

P356

P1433

International Journal of Hepatology

P1476

Improving Outcomes with Surgical Resection and Other Ablative Therapies in HCC

@en

P2093

Derek O'Reilly

http://www.w3.org/2001/XMLSchema#string

Rahul Deshpande

http://www.w3.org/2001/XMLSchema#string

P2860

A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma

Liver transplantation criteria for hepatocellular carcinoma should be expanded: a 22-year experience with 467 patients at UCLA

Management of hepatocellular carcinoma

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

Pretreatment assessment of hepatocellular carcinoma: expert consensus statement.

Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma.

Systematic review of randomized trials for hepatocellular carcinoma treated with percutaneous ablation therapies.

An intention-to-treat analysis of liver transplantation for hepatocellular carcinoma using organ procurement transplant network data.

Portal vein embolization before right hepatectomy: prospective clinical trial.

Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: an intention-to-treat analysis.

P304

686074

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4061/2011/686074

http://www.w3.org/2001/XMLSchema#string

P478

2011

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-06-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51712197

http://www.w3.org/2001/XMLSchema#string

P698

21994867

http://www.w3.org/2001/XMLSchema#string

P932

3170839

http://www.w3.org/2001/XMLSchema#string